Axios national political correspondent Alex Thompson, the co-author of the new book 'Original Sin,' on former President Biden's cognitive decline, told CNN on Saturday about one anecdote in the ...

Enter freshman forward Mick Thompson. The Mississauga, Ontario native has already left a mark on the team, earning NCAA Rookie of the Month honors in March. He is also the first rookie at Harvard ...

SAN FRANCISCO, May 23, 2025 – Nuvation Bio Inc. (NUVB), a pharmaceutical company specialized in developing therapeutic candidates for oncology with a market capitalization of $784 million, announced ...

SAN FRANCISCO, May 23, 2025 – Nuvation Bio Inc. (NUVB), a pharmaceutical company specialized in developing therapeutic candidates for oncology with a market capitalization of $784 million ...

Nuvation Bio’s lead asset, taletrectinib, is poised to potentially reshape the company’s trajectory. The drug, designed to treat ROS1-positive NSCLC, is currently under priority review with a PDUFA ...

Nuvation Bio’s lead asset, taletrectinib, is poised to potentially reshape the company’s trajectory. The drug, designed to treat ROS1-positive NSCLC, is currently under priority review with a ...

The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc.

2025--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that additional results ...

The drug is under Priority Review by the U.S. Food and Drug Administration (FDA) and has a Prescription Drug User Fee Act (PDUFA) date of June 23, 2025 Nuvation Bio Inc. (NYSE: NUVB), a global ...